TruAlt Bioenergy: Purchase of additional shares by Nirani Holdings Private Limited in the Company
TruAlt Bioenergy (TRUALT) filed a disclosure titled "Purchase of additional shares by Nirani Holdings Private Limited in the Company". The company is valued at about ₹3,789 crore.
What happened
TruAlt Bioenergy (TRUALT) filed a disclosure with the exchanges on 28 September 2026 at 04:32 PM titled "Purchase of additional shares by Nirani Holdings Private Limited in the Company".
Company snapshot
TruAlt Bioenergy is a small-cap company, with a market value of about ₹3,789 crore.
The stock last traded at ₹441.9, against a 52-week range of ₹310.2–₹542 (18.5% below the high).
Before this filing the shares had moved +1.9% over the month and −2.5% over three months. Average daily turnover over the last 20 sessions was about ₹10.39 crore.
Promoters held 70.55% at the end of Q1 FY27; 36.85% of promoter shares were pledged. Foreign institutions owned 0.58% and domestic institutions 8.36%.
What history shows
This is not the company's first corporate update disclosure: BCEIE has 8 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 0.3% on average the next trading day and was down 0.6% on average after five days (5 filings with price data).
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 23 Sept 2026 | The Intimation | +3.5% | — |
| 21 Aug 2026 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And… | −2.4% | −3.7% |
| 28 Jul 2026 | Corporate update | +4.0% | +10.1% |
In the news
Recent coverage elsewhere (links open the original publisher):
- TruAlt Bioenergy pays ₹5.49 lakh fines, appoints woman director
- TruAlt Bioenergy (NSE:TRUALT): Why Did Its Board Comment on Exchange Fines?
- TruAlt Bioenergy promoter pledges 14 lakh shares to Jio Credit
- TruAlt promoter group entity NHPL acquires 69,575 shares on Sep 16
- TruAlt promoter group entity NHPL acquires 50,000 shares on Sep 17
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.